Diagnosis of Genetically Inherited disease Flashcards
Uses of diagnostic testing
1) confirming/refuting clinical diagnosis
2) Assessing carrier status
3) Prenatal diagnosis (confirming ultrasound results)
4) Predictive testing (adult onset inherited disorders)
When testing/screening is appropriate
If intervention is available and if early diagnosis can reduce disease morbidity or mortality
-e.g. BRCA1 (5000-10000 carriers) or CFTR
Chromosome analysis: Karyotyping
Can observe chromosomes:
- finding abnormalities (number/aneuploidy or structure)
- Only able to observe in actively dividing cells
- observed using G-banding staining (Giemsa stain)
Types of specimens for chromosome studies
1) Containing spontaneously proliferating cells:
- bone marrow, lymph nodes, solid tumours, chrorionic villi
2) Specimens routinely cultured in the lab:
- blood lymphocytes, amniotic fluid samples, tissue biopsies, long term CVS
Chorionic Villus Sampling
Done in weeks 12-14 of pregnancy
- sampling of the extra embryonic tissue (chorion) derived from conceptus
- intrusive and risky (miscarriage rate = 1.5%
Amniocentesis
Done in weeks 18-20
- sampling the amnion
- less intrusive & safer
Karyotyping with Giemsa stain
Bright-field G-banding done to observe chromosomes
- G-banding involves trypsin digestion of chromosomes followed by DNA staining with Giemsa (G bands stain dark)
Patterns of banding shown in idiograms
- Differentiates G bands, R bands, Centromere (C bands) and non-centromeric heterochromatin
- chromosomes can then be classified by their topography (size, centromere position, chromomere, heterochromatin patterns)
Identifying microdeletions using FISH
Fluorescent In Situ Hybridization performed on dividing or non-dividing cells
3 types of FISH probe:
1) Repetitive sequences (inc. centromeres)
2) DNA segments that will bind to & cover entire length of chromosome
3) DNA segments from specific genes on a chromosome that have been previously identified
Fluorescent tag localises specific microdeletion positions
Uses of Cytogenetics
Pregnant women:
- diagnosing Trisomy 21 when indicative features of Down’s are observed
Children with developmental/phenotypic problems
- understanding cause of disease
Couples with reproductive problems
DNA analysis: OLA
Oligonucleotide Ligation Assay
- non-PCR method relying on DNA hybridization (very specific technique relying on ligation of 2 strands with a ligase (no polymerases))
If microdeletion is present, ligation fails (mis-match of oligonucleotide strand with chromosome)
- gel electrophoresis shows if ligation occured (bigger band = ligation)
- fluorescent tagging also used
DNA analysis: Sanger (chain termination) Sequencing
Synthesising new DNA strands complementary to single-stranded template but employing dideoxynucleotides:
- ddNTPs prevent further DNA extension
- tagged ddNTPs loaded into sequencing trace to identify DNA sequence (order of ddNTPs)
Identifies exons and mutations (e.g. MEGF10)
MEGF10 satellite cell regulator mutation
Causes a myopathy known as EMARDD (Early onset Myopathy, Areflexia, Respiratory Distress & Dysphagia)
Homozygous nonsense mutation, exon 13